A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
This study is planned to evaluate the safety and efficacy of L059 (levetiracetam) in
 long-term administration in patients who completed N01020 [NCT00160165] or N01221
 [NCT00280696].
Inclusion Criteria:

 -  Patients who participated in study N01221 [NCT00280696] and completed the evaluation
 period and transition period or patients who participated in study N01020
 [NCT00160615]

 Exclusion Criteria:

 -  Female patients during pregnancy, delivery and lactation, or suspected of pregnancy